首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position.
【2h】

Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position.

机译:喹诺酮类药物对分枝杆菌的构效关系:8位结构修饰的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of quinolones with substitutions at the 8 position has been prepared as part of a study to examine the relationship between structural modifications at this position and activity against mycobacteria. The compounds were prepared by procedures described in the literature and were evaluated for their activities against Mycobacterium fortuitum and Mycobacterium smegmatis. The activities of the compounds against these two organisms were used as a measure of Mycobacterium tuberculosis activity. The results demonstrate that the contribution of the 8 position to antimycobacterial activity was dependent on the substituent at N-1 and was in the order (i) COMe approximately CBr > CCI > CH approximately CF approximately COEt > N > CCF3 when N-1 was cyclopropyl; (ii) N approximately CH > CF > COMe when N-1 was 2,4-difluorophenyl; (iii) N > or = CH when N-1 was tert-butyl; and (iv) N > CH when N-1 was ethyl. In general, derivatives with piperazine substitutions at C-7 were slightly less active against mycobacteria than the analogs with pyrrolidine substitutions, regardless of the pattern of substitution at the 8 position. Several of the best compounds were evaluated for their potential side effects as well as their activities against Mycobacterium aurum, Mycobacterium avium-M. intracellulare, and M. tuberculosis. These agents exhibited biological profiles similar to or better than those of the positive controls ciprofloxacin and sparfloxacin.
机译:作为研究的一部分,准备了一系列在8位上具有取代基的喹诺酮,以研究该位置上的结构修饰与抗分枝杆菌活性之间的关系。通过文献中描述的程序制备化合物,并评价其对Fortuitum fortuitum和耻垢分枝杆菌的活性。化合物针对这两种生物的活性用作结核分枝杆菌活性的量度。结果表明,8位对分枝杆菌活性的贡献取决于N-1处的取代基,并且顺序为(i)当N-1为N时,COMe约CBr> CCI> CH约CF约COEt> N> CCF3环丙基(ii)当N-1为2,4-二氟苯基时,N约为CH> CF> COMe。 (iii)当N-1为叔丁基时,N>或= CH; (iv)当N-1为乙基时,N> CH。通常,与在8位上的取代方式无关,在C-7处具有哌嗪取代的衍生物对分枝杆菌的活性比具有吡咯烷取代的类似物的活性稍低。评价了几种最佳化合物的潜在副作用以及它们对金黄色分枝杆菌,鸟分枝杆菌-M的活性。细胞内和结核分枝杆菌。这些药物表现出与阳性对照环丙沙星和司帕沙星相似或更好的生物学特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号